+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Phenmedipham Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6153102
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Framing Phenmedipham’s Pivotal Role in Contemporary Weed Management and Sustainable Crop Protection in Global Agricultural Systems

Phenmedipham is a selective phenylcarbamate herbicide that has been utilized for decades to control broadleaf weeds in sugar and beets as well as in other key crop classes. Its mode of action enables contact inhibition of photosynthesis in susceptible plants, resulting in efficient weed suppression while preserving crop health. Over the years, incremental innovations in formulation and application technologies have enhanced its performance profile, allowing for improved dispersion, reduced drift, and accelerated uptake. At the same time, regulatory bodies have assessed its environmental and safety parameters, prompting refined usage protocols that align with evolving sustainability criteria.

This executive summary synthesizes the latest developments across regulatory, trade, technical, and market dimensions that influence phenmedipham adoption. By weaving together insights on policy shifts, tariff changes, and segmentation dynamics, it provides a holistic view designed to inform strategic decision making. In the following pages, key trends and actionable recommendations are presented within the context of shifting agricultural landscapes, enabling stakeholders to anticipate challenges and harness opportunities. Transitional analysis of each thematic area paves the way for a comprehensive understanding of how phenmedipham will continue to shape weed management practices on a global scale.

Examining the Dynamic Shifts in Agricultural Weed Control and Regulatory Environments Shaping Phenmedipham’s Competitive Landscape

Recent years have witnessed profound shifts in weed control paradigms as integrated pest management approaches gain traction alongside heightened sustainability goals. Regulatory environments have become more rigorous, compelling manufacturers and applicators to adopt advanced safety measures and to demonstrate ecological credentials. Furthermore, technological breakthroughs in precision agriculture have allowed for targeted spraying and automated distribution systems that reduce overall herbicide consumption and minimize off-target exposure. These trends have collectively elevated the competitiveness of established chemistries by reinforcing their compatibility with next-generation farming practices.

At the same time, the emergence of new active ingredients and biopesticide solutions has intensified the need for portfolio differentiation. Companies are investing in proprietary formulations and digital agronomy platforms to maintain alignment with global net-zero ambitions, while also enhancing resistance management strategies. Seamless integration of data analytics and remote sensing tools has optimized timing and dosage recommendations, ensuring that phenmedipham applications are both effective and sustainable. Consequently, this evolving landscape underscores the importance of responsive product development and regulatory foresight, as stakeholders navigate an increasingly complex matrix of environmental expectations, compliance mandates, and technological innovation.

Analyzing the Compounding Effects of United States Agricultural Tariff Adjustments Scheduled for 2025 on Phenmedipham Supply and Trade Dynamics

The imposition of adjusted United States tariffs on key agricultural inputs in 2025 marks a pivotal moment for global supply chains, particularly those centered on phenmedipham. In response to broader trade policy realignment, import duties on select intermediates and formulated products are set to recalibrate cost structures, affecting both domestic production and international sourcing. Agricultural suppliers and distributors are evaluating alternative procurement routes, reassessing inventory strategies, and renegotiating contracts to mitigate the impact of elevated transaction expenses.

Moreover, these tariff adjustments are projected to influence relationships with major exporting regions, prompting buyers to diversify supply bases and explore localized manufacturing partnerships. Reduced availability of low-cost feedstocks could lead to incremental price increases at the point of sale, altering the competitive positioning of phenmedipham relative to emerging herbicide chemistries. Feedback from industry stakeholders indicates that proactive supply chain mapping and scenario planning will be essential to maintain consistent product availability. As the market adapts to these new economic variables, companies with agile logistical frameworks and strong trade compliance capabilities will be best positioned to absorb transactional volatility and preserve steady distribution into critical agricultural zones.

Uncovering Actionable Insights Across Crop Types, Formulation Varieties, Application Techniques, Distribution Pathways, and Mode of Action for Phenmedipham

A nuanced appreciation of segmentation factors is essential to unlock value across phenmedipham’s diverse end-use applications. Variation in crop composition often dictates demand patterns; for instance, dense cereal acreages and expansive vegetable plantings exert distinct requirements for weed control efficacy and formulation stability, while oilseed and fruit and nut producers prioritize post-emergence flexibility to safeguard yield quality. Simultaneously, advancements in formulation science have expanded the toolkit available to agronomists, with emulsifiable concentrates offering rapid uptake in foliar systems, wettable powders catering to large-scale spraying operations, and suspension concentrates and granular options providing targeted soil interactions that align with seed-treatment and soil-treatment methodologies.

Application methods further differentiate performance propositions, as foliar spray systems deliver swift residual control while seed treatment applications embed protection at the embryonic stage, and soil treatment techniques establish protective barriers against early-stage weed competition. Distribution channels also shape market dynamics, with direct sales models fostering bespoke service bundles for large producers, distributor networks ensuring broad regional coverage, and e-commerce platforms capturing the preferences of smaller growers seeking streamlined procurement. Finally, mode of action distinctions between contact and translocated herbicides inform both formulation design and resistance management strategies. By integrating insights across these dimensions, stakeholders can tailor phenmedipham offerings to specific agronomic scenarios and optimize product positioning in heterogeneous markets.

Delving Into Regional Dynamics Influencing Phenmedipham Adoption and Market Drivers Across the Americas, EMEA, and Asia-Pacific Farming Communities

Geographic diversity exerts a profound influence on phenmedipham adoption, as agricultural traditions, climatic conditions, and regulatory frameworks vary across continents. In the Americas, expansive row crop operations leverage mechanized application infrastructures and value rapid-action herbicides that align with high-volume planting cycles. This emphasis on efficiency has driven demand for formulations that maximize coverage with minimal application time. By contrast, in Europe, Middle East and Africa, regulatory scrutiny and environmental stewardship priorities have elevated the importance of product stewardship programs and integrated resistance monitoring. Farmers in temperate zones often require flexible application windows and compatibility with cover crop rotations, which has informed tailored guidance on dosage rates and tank-mix protocols.

Moving to the Asia-Pacific region, heterogeneous farm sizes and cropping systems present both complexity and opportunity. Smallholder plots intermixed with larger commercial estates demand versatile packaging options and adaptable services, while tropical and subtropical climates necessitate formulations resilient to high rainfall and temperature variability. Regional distribution networks continue to evolve, with emerging e-commerce platforms and precision-agriculture partnerships facilitating access to remote communities. Understanding these regional nuances allows suppliers to calibrate supply chain logistics, regulatory submissions, and on-ground training initiatives to support optimal phenmedipham utilization and ensure that varietal market needs are met across disparate agricultural landscapes.

Profiling Leading Industry Players Driving Innovation, Strategic Partnerships, and Portfolio Development in Phenmedipham-Based Solutions

Market leadership in phenmedipham solutions is increasingly defined by integrated capabilities that span research, manufacturing, distribution, and agronomic support. Leading agrochemical firms have bolstered their product pipelines through strategic alliances, co-development agreements, and targeted acquisitions aimed at reinforcing herbicide portfolios. These moves are often complemented by investments in regional formulation plants that reduce lead times and enhance responsiveness to localized regulatory changes. Furthermore, collaborations with digital agronomy providers and equipment manufacturers are enabling real-time application monitoring, thereby improving performance consistency and fostering stronger customer loyalty.

At the same time, specialty players and formulators are carving out niches by concentrating on bespoke delivery systems that address specific crop and climatic challenges. Their agility in adapting formulation science to meet the evolving needs of diverse cropping patterns has positioned them as valuable partners for distributors seeking differentiated offerings. Many of these companies are also expanding technical support services, including field trial networks and resistance-management training programs, to underpin the efficacy and longevity of phenmedipham in integrated weed management strategies. Collectively, these industry developments highlight a competitive environment where innovation, service excellence, and supply chain robustness determine market share and long-term viability.

Strategic Recommendations for Industry Leaders to Enhance Phenmedipham Adoption, Regulatory Compliance, and Sustainable Herbicide Portfolio Management

To capitalize on emerging opportunities and navigate regulatory complexities, industry leaders should prioritize continuous investment in adaptive formulation technologies. By advancing emulsifiable concentrate and suspension concentrate platforms that deliver enhanced drift control and improved biodegradability, organizations can address stringent environmental thresholds while preserving herbicidal potency. Concurrently, integrating digital agronomy tools into service portfolios will enable data-driven application optimization, fostering precision usage and driving sustainable outcomes. Partnerships that extend into remote sensing and in-field monitoring will further strengthen risk-mitigation capabilities and reinforce customer confidence in phenmedipham solutions.

Additionally, agile supply chain strategies should be instituted to counteract tariff-driven cost fluctuations. This may involve diversifying sourcing arrangements, exploring regional co-manufacturing partnerships, and leveraging parallel distribution channels to maintain uninterrupted product flows. Leadership teams should also engage proactively with regulatory authorities to shape policy dialogues and align product stewardship initiatives with global best practices. Finally, enhancing educational outreach through virtual training modules and on-farm demonstration plots will deepen stakeholder understanding of mode-of-action principles and resistance-management protocols, thus preserving product efficacy across a variety of cropping systems.

Elucidating the Robust Research Methodology Underpinning the Comprehensive Assessment of Phenmedipham’s Market and Industry Dynamics

The insights presented in this summary are grounded in a multifaceted research framework that combines primary interviews, secondary data analysis, and qualitative scenario planning. Extensive discussions with agronomy experts, regulatory specialists, and supply chain executives provided firsthand perspectives on operational challenges, adoption barriers, and emerging innovations. Concurrently, technical literature reviews and public policy assessments furnished a robust contextual backdrop, ensuring that observations aligned with the most current environmental, regulatory, and technological benchmarks.

Complementary to these approaches, cross-sector database integration was applied to triangulate patterns in trade flows and distribution channel evolution, thereby illuminating the interplay between tariff adjustments and logistical dynamics. Iterative validation exercises, including peer reviews and stakeholder workshops, further enhanced the reliability of conclusions, enabling a clear linkage between empirical evidence and strategic recommendations. This diligent and transparent methodology underpins the credibility of the analysis and the viability of the recommended pathways for industry advancement.

Concluding Insights Highlighting Phenmedipham’s Strategic Importance and Future Considerations for Stakeholders in a Competitive Agricultural Market

Phenmedipham remains a cornerstone of broadleaf weed management due to its proven efficacy, adaptable formulation spectrum, and complementary role within integrated pest management programs. In light of shifting regulatory demands, evolving tariff landscapes, and growing sustainability imperatives, market participants are compelled to adopt holistic strategies that balance performance, compliance, and environmental stewardship. Organizations equipped with agile formulation platforms, data-centric service offerings, and resilient supply chain configurations will be best positioned to sustain growth and foster enduring customer partnerships.

Looking forward, ongoing collaboration between chemical developers, agronomic service providers, and regulatory bodies will be essential to refine usage guidelines and to safeguard resistance-management integrity. Emphasis on digital integration, stakeholder education, and proactive policy engagement will anchor phenmedipham’s value proposition in a competitive and rapidly evolving agricultural sector. By aligning strategic initiatives with these interdependent factors, stakeholders can reinforce the role of phenmedipham in driving productivity gains and supporting sustainable crop protection frameworks worldwide.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Crop
    • Cereals
    • Fruits & Nuts
    • Oilseeds
    • Vegetables
  • Formulation
    • Emulsifiable Concentrate
    • Granular
    • Suspension Concentrate
    • Wettable Powder
  • Application Method
    • Foliar Spray
    • Seed Treatment
    • Soil Treatment
  • Distribution Channel
    • Direct Sales
    • Distributor
    • E-Commerce
  • Mode Of Action
    • Contact
    • Translocated
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Bayer AG
  • Syngenta AG
  • Corteva, Inc.
  • BASF SE
  • FMC Corporation
  • UPL Limited
  • ADAMA Ltd.
  • Sumitomo Chemical Co., Ltd.
  • Nufarm Limited
  • Mitsubishi Chemical Holdings Corporation

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising regulatory scrutiny and data requirements impacting phenmedipham approval timelines in major markets
5.2. Shifting retailer demands for low-toxicity herbicides driving formulation innovation in phenmedipham products
5.3. Growing incidence of phenmedipham-resistant weed biotypes prompting development of combination herbicide solutions
5.4. Expansion of sugar beet acreage in Europe boosting demand for phenmedipham-based weed control programs
5.5. Increasing integration of digital agronomy platforms to optimize phenmedipham application timing and dosage
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Phenmedipham Market, by Crop
8.1. Introduction
8.2. Cereals
8.3. Fruits & Nuts
8.4. Oilseeds
8.5. Vegetables
9. Phenmedipham Market, by Formulation
9.1. Introduction
9.2. Emulsifiable Concentrate
9.3. Granular
9.4. Suspension Concentrate
9.5. Wettable Powder
10. Phenmedipham Market, by Application Method
10.1. Introduction
10.2. Foliar Spray
10.3. Seed Treatment
10.4. Soil Treatment
11. Phenmedipham Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributor
11.4. E-Commerce
12. Phenmedipham Market, by Mode Of Action
12.1. Introduction
12.2. Contact
12.3. Translocated
13. Americas Phenmedipham Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Phenmedipham Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Phenmedipham Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Bayer AG
16.3.2. Syngenta AG
16.3.3. Corteva, Inc.
16.3.4. BASF SE
16.3.5. FMC Corporation
16.3.6. UPL Limited
16.3.7. ADAMA Ltd.
16.3.8. Sumitomo Chemical Co., Ltd.
16.3.9. Nufarm Limited
16.3.10. Mitsubishi Chemical Holdings Corporation
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. PHENMEDIPHAM MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PHENMEDIPHAM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PHENMEDIPHAM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHENMEDIPHAM MARKET SIZE, BY CROP, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PHENMEDIPHAM MARKET SIZE, BY CROP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PHENMEDIPHAM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PHENMEDIPHAM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PHENMEDIPHAM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PHENMEDIPHAM MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PHENMEDIPHAM MARKET: RESEARCHAI
FIGURE 26. PHENMEDIPHAM MARKET: RESEARCHSTATISTICS
FIGURE 27. PHENMEDIPHAM MARKET: RESEARCHCONTACTS
FIGURE 28. PHENMEDIPHAM MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PHENMEDIPHAM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHENMEDIPHAM MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PHENMEDIPHAM MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PHENMEDIPHAM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PHENMEDIPHAM MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PHENMEDIPHAM MARKET SIZE, BY CEREALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PHENMEDIPHAM MARKET SIZE, BY CEREALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PHENMEDIPHAM MARKET SIZE, BY FRUITS & NUTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PHENMEDIPHAM MARKET SIZE, BY FRUITS & NUTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PHENMEDIPHAM MARKET SIZE, BY OILSEEDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PHENMEDIPHAM MARKET SIZE, BY OILSEEDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PHENMEDIPHAM MARKET SIZE, BY VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PHENMEDIPHAM MARKET SIZE, BY VEGETABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PHENMEDIPHAM MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PHENMEDIPHAM MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PHENMEDIPHAM MARKET SIZE, BY GRANULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PHENMEDIPHAM MARKET SIZE, BY GRANULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PHENMEDIPHAM MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PHENMEDIPHAM MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PHENMEDIPHAM MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PHENMEDIPHAM MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PHENMEDIPHAM MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PHENMEDIPHAM MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PHENMEDIPHAM MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PHENMEDIPHAM MARKET SIZE, BY SEED TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PHENMEDIPHAM MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PHENMEDIPHAM MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PHENMEDIPHAM MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PHENMEDIPHAM MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PHENMEDIPHAM MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PHENMEDIPHAM MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PHENMEDIPHAM MARKET SIZE, BY CONTACT, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PHENMEDIPHAM MARKET SIZE, BY CONTACT, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PHENMEDIPHAM MARKET SIZE, BY TRANSLOCATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PHENMEDIPHAM MARKET SIZE, BY TRANSLOCATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES PHENMEDIPHAM MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES PHENMEDIPHAM MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 75. CANADA PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 76. CANADA PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 77. CANADA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 78. CANADA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 79. CANADA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 80. CANADA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 81. CANADA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. CANADA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. CANADA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 84. CANADA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 85. MEXICO PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 86. MEXICO PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 87. MEXICO PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 88. MEXICO PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 89. MEXICO PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 90. MEXICO PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 91. MEXICO PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. MEXICO PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. MEXICO PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 94. MEXICO PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. UNITED KINGDOM PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 136. UNITED KINGDOM PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 137. GERMANY PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 138. GERMANY PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 139. GERMANY PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 140. GERMANY PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 141. GERMANY PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 142. GERMANY PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 143. GERMANY PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. GERMANY PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. GERMANY PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 146. GERMANY PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 147. FRANCE PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 148. FRANCE PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 149. FRANCE PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 150. FRANCE PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 151. FRANCE PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 152. FRANCE PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 153. FRANCE PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. FRANCE PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. FRANCE PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 156. FRANCE PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 163. RUSSIA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. RUSSIA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. RUSSIA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 166. RUSSIA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 167. ITALY PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 168. ITALY PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 169. ITALY PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 170. ITALY PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 171. ITALY PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 172. ITALY PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 173. ITALY PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. ITALY PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. ITALY PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 176. ITALY PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 177. SPAIN PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 178. SPAIN PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 179. SPAIN PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 180. SPAIN PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 181. SPAIN PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 182. SPAIN PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 183. SPAIN PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. SPAIN PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. SPAIN PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 186. SPAIN PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. SAUDI ARABIA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 206. SAUDI ARABIA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 216. SOUTH AFRICA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 217. DENMARK PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 218. DENMARK PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 219. DENMARK PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 220. DENMARK PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 221. DENMARK PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 222. DENMARK PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 223. DENMARK PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. DENMARK PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. DENMARK PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 226. DENMARK PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 233. NETHERLANDS PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. NETHERLANDS PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. NETHERLANDS PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 236. NETHERLANDS PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 237. QATAR PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 238. QATAR PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 239. QATAR PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 240. QATAR PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 241. QATAR PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 242. QATAR PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 243. QATAR PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. QATAR PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. QATAR PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 246. QATAR PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 247. FINLAND PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 248. FINLAND PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 249. FINLAND PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 250. FINLAND PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 251. FINLAND PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 252. FINLAND PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 253. FINLAND PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. FINLAND PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. FINLAND PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 256. FINLAND PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 263. SWEDEN PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. SWEDEN PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. SWEDEN PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 266. SWEDEN PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 273. NIGERIA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. NIGERIA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. NIGERIA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 276. NIGERIA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 277. EGYPT PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 278. EGYPT PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 279. EGYPT PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 280. EGYPT PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 281. EGYPT PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 282. EGYPT PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 283. EGYPT PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. EGYPT PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. EGYPT PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 286. EGYPT PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 287. TURKEY PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 288. TURKEY PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 289. TURKEY PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 290. TURKEY PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 291. TURKEY PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 292. TURKEY PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 293. TURKEY PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. TURKEY PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. TURKEY PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 296. TURKEY PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 303. ISRAEL PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. ISRAEL PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. ISRAEL PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 306. ISRAEL PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 307. NORWAY PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 308. NORWAY PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 309. NORWAY PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 310. NORWAY PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 311. NORWAY PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 312. NORWAY PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 313. NORWAY PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. NORWAY PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. NORWAY PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 316. NORWAY PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 317. POLAND PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 318. POLAND PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 319. POLAND PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 320. POLAND PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 321. POLAND PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 322. POLAND PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 323. POLAND PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. POLAND PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. POLAND PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 326. POLAND PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 327. SWITZERLAND PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 328. SWITZERLAND PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 329. SWITZERLAND PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 330. SWITZERLAND PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 331. SWITZERLAND PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 332. SWITZERLAND PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 333. SWITZERLAND PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. SWITZERLAND PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. SWITZERLAND PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 336. SWITZERLAND PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 338. ASIA-PACIFIC PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 340. ASIA-PACIFIC PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 341. ASIA-PACIFIC PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 342. ASIA-PACIFIC PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 343. ASIA-PACIFIC PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. ASIA-PACIFIC PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. ASIA-PACIFIC PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 346. ASIA-PACIFIC PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 347. ASIA-PACIFIC PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 348. ASIA-PACIFIC PHENMEDIPHAM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 349. CHINA PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 350. CHINA PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 351. CHINA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 352. CHINA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 353. CHINA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 354. CHINA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 355. CHINA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 356. CHINA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 357. CHINA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 358. CHINA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 359. INDIA PHENMEDIPHAM MARKET SIZE, BY CROP, 2018-2024 (USD MILLION)
TABLE 360. INDIA PHENMEDIPHAM MARKET SIZE, BY CROP, 2025-2030 (USD MILLION)
TABLE 361. INDIA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 362. INDIA PHENMEDIPHAM MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 363. INDIA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
TABLE 364. INDIA PHENMEDIPHAM MARKET SIZE, BY APPLICATION METHOD, 2025-2030 (USD MILLION)
TABLE 365. INDIA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 366. INDIA PHENMEDIPHAM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 367. INDIA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2018-2024 (USD MILLION)
TABLE 368. INDIA PHENMEDIPHAM MARKET SIZE, BY MODE OF ACTION, 2025-2030 (USD MILLION)
TABLE 369. JAPAN PHENMEDIPHAM MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Phenmedipham Market report include:
  • Bayer AG
  • Syngenta AG
  • Corteva, Inc.
  • BASF SE
  • FMC Corporation
  • UPL Limited
  • ADAMA Ltd.
  • Sumitomo Chemical Co., Ltd.
  • Nufarm Limited
  • Mitsubishi Chemical Holdings Corporation